Female Reproductive Drug Flashcards
Hormone Replacement Therapy
ESTROGENS
many symptoms of menopause attributed to decreased estrogen
- osteoporosis
2.hot flushes
3.atrophic vaginitis
Contraceptive Drugs
Combination of estrogen and progesterone
ORAL: = LOESTRIN (norethindone /ethyl estradiol
TRANSVAGINAL= NORELGESTROMINE / ETHYL ESTRADIOL
INTRAVAGINAL= NUVARING (etonogestrel-ethyl estradiol)
**PROGESTIN ONLY= medroxy (depo provera) every 3 months
BBW: loss of bone mineral density
it can prevent pregnancy but it cant prevent STD
CONTRAINDICATIONS/WARNINGS
- pregnancy lactation (category x)
- hx of cv disease (DVT, MI,CVA)
3.***SMOKING rf Thrombus formation
ANTIBIOTICS: contraceptive becomes less effective
BBW
RF increase CV events
DVT , PE , MI , ISCHEMIC CVA
RF increase endometrial or breast cancer
ADVERSE EFFECT
BEGELS w CREAM CHEESE
Breakthrough bleeding
Edema
GI effects
Embolism
Lost libido
Stop smoking
Contraceptives less effective with antibiotics
Cardiovascular events increase risk
- breakthrough bleeding /menstrual irregularities
- change libido
- fluid retention *edema * headache * dizziness
- GI effects ( NV, Abd cramps,bloating)
- Thromboembolism ( DVT , PE , CVA )
NURSES**
- Assess age , lifestyle, mens cycle , child bearing status , wellness exam , cancer screenings
- RF cv disease , esp thromboembolism
INTERVENTIONS
- counsel tobacco
2.oral contraceptive , take at the same time each day missed dose follow package direction use alteration form of contraception for 7 days
3.less effective when taking antibiotics
4.may take with food if gi stress occurs
OSTEOPOROSIS Biphosphonates
ALENDRONATE (fosamax)
MOA:
INDIC:
ROUTE/DOSE:
CONTRAINDIC:
AE:
NURSING:
MOA: slow bone resorption
INDIC: osteoporosis
ROUTE/DOSE: oral daily /weekly
CONTRAINDIC:
1. esophageal or gastric ulcer
2.esophagitis
AE:
1.NA/DI
2.Esophageal erosion (GI Problem)
NURSING:
- take in the am with full glass of water (no food just water) 30 minutes prior to food or drink
- sit upright for at least 30 minutes after administration to minimize reflux)
- limit use to 5 years
OSTEOPOROSIS Estrogen Receptor Modulators
RALOXIFENE (Evista)
MOA
INDIC
CONTRAINDIC
AE
MOA
1.increases bone mineral density without stimulating the endometrium
- modulates effects endogenous estrogen at specific receptor sites
INDIC prevention and treatment of osteoporosis in post menopausal receptor sites
CONTRAINDIC pregnancy /lactation , hx, dvt , or smoking
AE
1.venous thromboembolism
2. vaginal bleeding
The nurse is providing teaching for a patient who is to receive progestin (medroxy) therapy. Which statement is correct to include in the teaching session?
a. “If you miss a dose, double-up on the next dose.”
b. “There’s no need to be concerned about breast lumps or bumps that occur.”
c. “Be sure to report any weight gain of 5 pounds or more per week.”
d. “Take the medication on an empty stomach to enhance absorption.”
c. “Be sure to report any weight gain of 5 pounds or more per week.”
he nurse recognizes that use of estrogen drugs is contraindicated in which patient?
a. A patient who has atrophic vaginitis
b. A patient who has inoperable prostate cancer
c. A woman who has just given birth and wants to prevent postpartum lactation
d. A woman with a history of thrombophlebitis
d. A woman with a history of thrombophlebitis
Estrogenic drugs are contraindicated in people who have active thromboembolic disorders and in those with histories of thromboembolic disease.
Atrophic vaginitis and inoperable prostate cancer are potential INDICATION for estrogen therapy
A patient is being treated for secondary amenorrhea. The nurse expects which drug to be used to treat this problem?
a. Methylergonovine (Methergine)
b. Estradiol transdermal (Estraderm)
c. Raloxifene (Evista)
d. Medroxyprogesterone (Provera)
d. Medroxyprogesterone (Provera)
Medroxyprogesterone, a progestin, is one of the drugs most commonly used for secondary amenorrhea
A 51-year-old woman will be taking selective estrogen receptor modulators (SERMs) as part of treatment for postmenopausal osteoporosis. The nurse reviews potential contraindications, including which condition?
a. Hypocalcemia
b. Breast cancer
c. Stress fractures
d. Venous thromboembolism
d. Venous thromboembolism
SERMs such as raloxifene are contraindicated in women with a venous thromboembolic disorder, including deep vein thrombosis, pulmonary embolism, or a history of such disorders.
A 51-year-old woman will be taking selective estrogen receptor modulators (SERMs) as part of treatment for postmenopausal osteoporosis. The nurse reviews potential contraindications, including which condition?
a. Hypocalcemia
b. Breast cancer
c. Stress fractures
d. Venous thromboembolism
d. Venous thromboembolism
SERMs such as raloxifene are contraindicated in women with a venous thromboembolic disorder, including deep vein thrombosis, pulmonary embolism, or a history of such disorders.
During a follow-up visit, a patient who has been on estrogen therapy admits that she has continued to smoke cigarettes. The nurse will remind the patient that smoking while on estrogen may lead to increased:
a. incidence of nausea.
b. risk for thrombosis.
c. levels of triglycerides.
d. tendency to bleed during menstruation.
b. risk for thrombosis.
Smoking should be avoided during estrogen therapy because it adds to the risk for thrombosis formation.
During a follow-up visit, a patient who has been on estrogen therapy admits that she has continued to smoke cigarettes. The nurse will remind the patient that smoking while on estrogen may lead to increased:
a. incidence of nausea.
b. risk for thrombosis.
c. levels of triglycerides.
d. tendency to bleed during menstruation.
b. risk for thrombosis.
Smoking should be avoided during estrogen therapy because it adds to the risk for thrombosis formation.
A woman visits a health center requesting oral contraceptives. Which laboratory test is most important for the nurse to assess before the patient begins oral contraceptive therapy?
a. Complete blood count
b. Serum potassium level
c. Vaginal cultures
d. Pregnancy test
d. Pregnancy test
Pregnancy should be ruled out before beginning oral contraceptive therapy because the medications can be harmful to the fetus; they are classified as pregnancy category X.
The nurse is providing patient teaching about the oral bisphosphonate alendronate (Fosamax). Which statement by the patient indicates a good understanding of when this drug should be taken?
a. “I will take it in the evening just before bedtime.”
b. “I will take it in the morning with an 8-ounce glass of water.”
c. “I will take it with the first bite of the morning meal.”
b. “I will take it in the morning with an 8-ounce glass of water.”
*Bisphosphonates must be taken in the morning, with 6 to 8 ounces of plain water, to prevent esophageal erosion.
- In addition, the patient must sit upright for 30 minutes after taking them.